Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02798419 · ClinicalTrials.gov registry record · Phase 2
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
A Phase 2 study of Common Warts, sponsored by Dr. Reddys Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 12
- Study locations
NCT02798419 is a Phase 2 study of Common Warts that has completed, run by Dr. Reddys Laboratories. The registered enrollment target is 50 participants, below the 141-participant average among 3 other Common Warts trials with a reported enrollment target (65% lower). The trial reports 12 study locations across 10 states.
The verdict
NCT02798419, a Phase 2 study of Common Warts, has completed, sponsored by Dr. Reddys Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 12
- Study locations
Study Summary
DFD05 vs. Active01 in the treatment of common warts
Conditions Studied
Interventions
- DRUG DFD05 Cream
- DRUG Active01 Cream
Study Locations (12)
California
- Investigational Site #4 - Fremont
- Investigational Site #11 - Sacramento
Texas
- Investigational Site #5 - Austin
- Investigational Site #7 - College Station
Arkansas
- Investigation Site #1 - Hot Springs
Colorado
- Investigational Site #2 - Colorado Springs
Florida
- Investigational Site #12 - Tampa
Georgia
- Investigational Site #9 - Marietta
Illinois
- Investigational Site #3 - Arlington Hts
Louisiana
- Investigational Site #10 - Crowley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02798419
The ClinicalTrials.gov registry entry for NCT02798419 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 3 other Common Warts trials with a reported enrollment target (65% lower). The listed sponsor is Dr. Reddys Laboratories, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Common Warts appearing as the primary indexed condition, and to 2 interventions - of which DFD05 Cream is the first listed.
NCT02798419 reports 12 study locations spanning 10 distinct geographic areas - top geographies include California, Texas, Arkansas.
Frequently Asked Questions
What is clinical trial NCT02798419 about?
NCT02798419 is a clinical study titled "Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts". DFD05 vs. Active01 in the treatment of common warts
What is the current status of trial NCT02798419?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2016-01. Estimated completion is 2016-08.
What conditions does trial NCT02798419 study?
This clinical trial studies the following conditions: Common Warts.
What interventions are being tested in trial NCT02798419?
The interventions under investigation include: DFD05 Cream (DRUG), Active01 Cream (DRUG).
Who is sponsoring clinical trial NCT02798419?
This trial is sponsored by Dr. Reddys Laboratories, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02798419 being conducted?
This trial has 12 study locations across Arkansas, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Common Warts
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.